Celyad Oncology S.A.

CLYYF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents$790$4,200$6,229$7,004
Short-Term Investments$0$0$0$0
Receivables$760$908$74$380
Inventory$255$417$0$0
Other Curr. Assets$652$990$2,359$3,737
Total Curr. Assets$2,457$6,515$8,662$11,121
Property Plant & Equip (Net)$1,337$1,493$1,669$1,830
Goodwill$0$0$427$0
Intangibles$357$405$26$48
Long-Term Investments$1,468$1,420$1,946$2,804
Tax Assets$0$0$1-$2,462
Other NC Assets$79$95$115$2,941
Total NC Assets$3,241$3,413$4,184$5,161
Other Assets$0$0$0$0
Total Assets$5,698$9,928$12,846$16,282
Liabilities
Payables$921$1,233$1,060$1,243
Short-Term Debt$77$284$310$312
Tax Payable$0$0$0$0
Deferred Revenue$654$785$0$509
Other Curr. Liab.$2,067$544$1,046$868
Total Curr. Liab.$3,719$2,846$2,416$2,932
LT Debt$754$17,394$834$17,533
Deferred Rev, NC$4,258$4,291$0$4,576
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$68$1,517$6,331$1,568
Total NC Liab.$5,080$23,202$7,165$23,677
Other Liabilities$0$0$0-$16,631
Cap. Leases$754$905$989$1,058
Total Liabilities$8,799$26,048$9,581$9,978
Equity
Pref Stock$0$0$0$0
Common Stock$8,216$8,216$8,216$32,949
Retained Earnings-$367,871-$364,196-$361,417-$358,372
AOCI$356,554$339,860$356,466$331,727
Other Equity$0$0$0$0
Total Equity-$3,101-$16,120$3,265$6,304
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$5,698$9,928$12,846$16,282
Net Debt$41$13,478-$5,085$10,841
Celyad Oncology S.A. (CLYYF) Financial Statements & Key Stats | AlphaPilot